Newsletter | April 1, 2025

04.01.25 -- Drug Design At The Speed Of Quantum

FEATURED EDITORIAL

Drug Design At The Speed Of Quantum

Using quantum computing to optimize drug design can identify the most effective molecular structures, and new therapeutic pathways could open the door to more personalized drugs.

INDUSTRY INSIGHTS

The Complexities Of Early Phase Ophthalmic Drug Development

Navigating the landscape of ophthalmic drug development can be challenging. Check out this scientific journal that outlines potential challenges, and how to overcome them.

From Powder To Particles With Jet Milling

Gain valuable insights into the jet milling process and Quality by Design approach for inhalation drug delivery and their potential applications in drug development.

Integrated First-In-Human Services for Streamlined Development and Manufacturing

Lonza's SimpliFiH Solutions offering is designed to simplify and accelerate the development pathway, even for APIs with challenging properties, such as low aqueous solubility and poor bioavailability.

Design Of Experiments Approach To Enabling Studies For Process Validation

A recent project applied process improvement methodology to the process validation step that ultimately provided not only an optimized, robust process but also an economic advantage.

MOST POPULAR NEWS

Charles River & Valo Health Identify A Potential Therapeutic For Lupus Using Logica

A Breakthrough Moment: Mcmaster Researchers Discover New Class Of Antibiotics

ReCode Therapeutics Receives U.S. FDA ODD For RCT2100

Predictive Oncology Develops Predictive Models Derived From 21 Unique Compounds

SOLVE FSHD Announces Strategic Collaboration With Transcripta Bio

FDA Approves New Prostate Cancer Imaging Agent Gozellix

Redwire Awarded NASA Contract To Expand Pharmaceutical Drug Development In Space

GV20 Therapeutics Announces Collaboration Agreement With MTPC

Beam Therapeutics Announces Clearance Of IND Application For BEAM-302

Palatin's Oral MC4R Agonist PL7737 Receives FDA ODD For Obesity Due To LEPR Deficiency

Shionogi Submits sNDA For Ensitrelvir In Japan For The Post-Exposure Prophylaxis Of COVID-19

SOLUTIONS

Seamless Integration And Scalability For Reliable Biomanufacturing

This Is Your Team At Cambrex